PATENT CLAIM ANALYSIS

Application Number: 16122360
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-02
Patent Classification: ["424", "451000"]

Abstract:
Abuse-resistant therapeutic pharmaceutical formulations include a cationic drug and at least one anionic polymer. Particular arrangements of the cationic drug and the at least one anionic polymer prevent the cationic drug from being extracted from the formulations in solvents and conditions commonly used by drug abusers attempting to isolate the cationic drug from its formulation.

Claim (Index 13):
The pharmaceutical formulation of  claim 12 , wherein the cationic drug-poly(acrylic acid) homopolymer, copolymer, terpolymer, or interpolymer complex is made by reacting the cationic drug and the poly(acrylic acid) homopolymer, copolymer, terpolymer, or interpolymer in an aqueous solution at a pH range of greater than the pKa\u22121 of the poly(acrylic acid) homopolymer, copolymer, terpolymer, or interpolymer and lower than the pKa+1 of the cationic drug.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 97.0
- Lexical Diversity: 1.62857
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14589839', '14704836', '14841428', '15076253', '10607446']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7260832351879493
- 35 USC 102 Novelty (BERT): 0.4783012020827614
- Combined Prediction Score: 0.7013050318774305
- Mean Citation Score: 230.719124
- Max Citation Score: 240.37888
- Similarity Product: 169.2001097406006

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test